OTC PEDIATRIC DOSING "PREFERRED AND PRACTICAL BASIS" TO BE DISCUSSED
This article was originally published in The Tan Sheet
Executive Summary
OTC PEDIATRIC DOSING "PREFERRED AND PRACTICAL BASIS" TO BE DISCUSSED at a Jan. 13 meeting of the Nonprescription Drugs Advisory Committee. According to FDA, the advisory committee will be asked to address several questions related to pediatric dosing of over-the-counter products used by children under 12, including "what is the most preferred and practical basis for determining and labeling OTC systemic pediatric dosages." FDA suggested several possible ways to establish pediatric doses, including "age, weight, height, length, body surface area," or a combination of approaches.